YKL-40 protein as a marker of asthma

K. Specjalski, K. Kuziemski, K. Lewandowska, E. Jassem (Poland)

Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Session: Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Session type: Thematic Poster Session
Number: 4635
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Specjalski, K. Kuziemski, K. Lewandowska, E. Jassem (Poland). YKL-40 protein as a marker of asthma. Eur Respir J 2010; 36: Suppl. 54, 4635

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The chitinase-like protein YKL-40 is elevated in children with severe asthma
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011


The serum YKL-40 is a useful biomarker for asthma
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017

Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001

COPD, asthma and C-reactive protein
Source: Eur Respir J 2006; 27: 874-876
Year: 2006


The relationship between the serum YKL-40 level and severity of asthma
Source: Annual Congress 2012 - Asthma management
Year: 2012


Is YKL-40 a prognostic marker in sarcoidosis?
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Characterisation of asthma subgroups associated with circulating YKL-40 levels
Source: Eur Respir J, 50 (4) 1700800; 10.1183/13993003.00800-2017
Year: 2017



Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
Source: Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017
Year: 2018



C-reactive protein and childhood asthma
Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases
Year: 2008

Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018

Serum concentration of C-reactive protein is not a good marker of bronchial hyperreactivity
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Year: 2007


Analysis of IgE and C-reactive protein as possible predictors of exacerbation patients with asthma
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011

Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Significance of serum YKL-40, S100A8, S100A9, calprotectin, periostin and LRG1 levels in patients with newly diagnosed, controlled and uncontrolled asthma
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018



Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma
Source: Eur Respir J, 51 (3) 1701377; 10.1183/13993003.01377-2017
Year: 2018



High sensitivity C-reactive protein in asthma
Source: Eur Respir J 2006; 27: 908-912
Year: 2006



Visfatin as a possible serum biomarker in COPD
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019


Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

YKL-40, IL-8 and IL-6 in clusters of adult-onset asthma
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019



Serum CC16 is a potential predictor for IPF diagnosis and prognosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020